Proteomic and Metabolomic Profiles in Atherothrombotic Vascular Disease

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

1. 1.
   Bhatt DL, Steg PG, Ohman EM, et al.: International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006, 295:180–189.CrossRefPubMedGoogle Scholar
2. 2.
   Baumgartner I, Hirsch AT, Abola MT, et al.: Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: data from the Reduction of Atherothrombosis for Continued Health (REACH) Registry. J Vasc Surg 2008, 48:808–814.CrossRefPubMedGoogle Scholar
3. 3.
   Cacoub PP, Abola MT, Baumgartner I, et al.: Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Atherosclerosis 2009, 204:e86–e92.CrossRefPubMedGoogle Scholar
4. 4.
   Kolodgie FD, Gold HK, Burke AP, et al.: Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003, 349:2316–2325.CrossRefPubMedGoogle Scholar
5. 5.
   Takaya N, Yuan C, Chu B, et al.: Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study, Circulation 2005, 111:2768–2775.CrossRefPubMedGoogle Scholar
6. 6.
   Virmani R, Kolodgie FD, Burke AP, et al.: Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage, Arterioscler Thromb Vasc Biol 2005, 25:2054–2061.CrossRefPubMedGoogle Scholar
7. 7.
   Levy AP, Moreno PR: Intraplaque hemorrhage. Curr Mol Med 2006, 6:479–488.CrossRefPubMedGoogle Scholar
8. 8.
   Sluimer JC, Kolodgie FD, Bijnens AP, et al.: Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage. J Am Coll Cardiol 2009, 53:1517–1527.CrossRefPubMedGoogle Scholar
9. 9.
   Coutard M, Touat Z, Houard X, et al.: Thrombus versus wall biological activities in experimental aortic aneurysms. J Vasc Res 2009, 47:355–366.CrossRefPubMedGoogle Scholar
10. 10.
    Swedenborg J, Eriksson P: The intraluminal thrombus as a source of proteolytic activity. Ann N Y Acad Sci 2006, 1085:133–138.CrossRefPubMedGoogle Scholar
11. 11.
    Wei Y, Czuchlewski D, Peerschke EI: Development of proteomic signatures of platelet activation using Surface-Enhaced Laser Desrption/Ionization technology in a clinical setting. Am J Clin Pathol 2008, 129:862–869.CrossRefGoogle Scholar
12. 12.
    Hernandez-Ruiz L, Valverde F, Jimenez-Nuñez MD, et al.: Organellar proteomics of human platelet dense granules reveals that 14-3-3zeta is a granule protein related to atherosclerosis. J Proteome Res 2007, 6:4449–4457.CrossRefPubMedGoogle Scholar
13. 13.
    Thandavarayan RA, Watanabe K, Ma M, et al.: 14-3-3 protein regulates Ask1 signaling and protects against diabetic cardiomyopathy. Biochem Pharacol 2008, 75:1797–1806.CrossRefGoogle Scholar
14. 14.
    Tucker KL, Kaiser WJ, Bergeron AL, et al.: Proteomic analysis of resting and thrombin-stimulated platelets reveals the translocation and functional relevance of HIP-55 in platelets. Proteomics 2009, 9:4340–4354.CrossRefPubMedGoogle Scholar
15. 15.
    Garcia A, Senis YA, Antrobus R, et al.: A global proteomics approach identifies novel phosphorylated signalling proteins in GPVI-activated platelets: involvement of G6f, a novel platelet Grb2-binding membrane adapter. Proteomics 2006, 6:5332–5343.CrossRefPubMedGoogle Scholar
16. 16.
    Kaiser WJ, Holbrook LM, Tucker KL, et al.: A functional proteomics method for the enrichment of Peripherals membrane proteins reveals the collagen binding protein Hsp47 is exposed on the surface of activated human platelets. J Proteome Res 2009, 8:2903–2914.CrossRefPubMedGoogle Scholar
17. 17.
    Roux-Dalvai F, Gonzalez de Peredo A, Simó C, et al.: Extensive analysis of the cytoplasmic proteome of human erythrocytes using the peptide ligand library technology and advanced mass spectrometry. Mol Cell Proteomics 2008, 7:2254–2269.CrossRefPubMedGoogle Scholar
18. 18.
    Ringrose JH, van Solinge WW, Mohammed S, et al.: Highly efficient depletion strategy for the two most abundant erythrocyte soluble proteins improves proteome coverage dramatically. J Proteome Res 2008, 7:3060–3063.CrossRefPubMedGoogle Scholar
19. 19.
    Baetta R, Corsini A: Role of polymorphonuclear neutrophils in atherosclerosis: current state and future perspectives. Atherosclerosis 2009 (in press).Google Scholar
20. 20.
    Naruko T, Ueda M, Haze K, et al.: Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 2002, 3:2894–2900.CrossRefGoogle Scholar
21. 21.
    Leclercq A, Houard X, Philippe M, et al.: Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment. J Leukoc Biol 2007, 82:1420–1429.CrossRefPubMedGoogle Scholar
22. 22.
    Lominadze G, Powell DW, Luerman GC, et al.: Proteomic analysis of human neutrophil granules. Mol Cell Proteomics 2005, 4:1503–1521.CrossRefPubMedGoogle Scholar
23. 23.
    Karadag B, Kucur M, Isman FK, et al.: Serum chitotriosidase activity in patients with coronary artery disease. Circ J 2008, 72:71–75.CrossRefPubMedGoogle Scholar
24. 24.
    Xu P, Crawford M, Way M, et al.: Subproteome analysis of the neutrophil cytoskeleton. Proteomics 2009, 9:2037–2049.CrossRefPubMedGoogle Scholar
25. 25.
    Dittrich M, Birschmann I, Mietner S, et al.: Platelet protein interactions. Maps signaling components and phosphorylation groundstate. Arterioscler Thromb Vasc Biol 2008, 28:1326–1331.CrossRefPubMedGoogle Scholar
26. 26.
    Lewandrowski U, Wortelkamp S, Lohrig K, et al.: Platelet membrane proteomics: a novel repository for functional research. Blood 2009, 114:e10–19.CrossRefPubMedGoogle Scholar
27. 27.
    Goodman SR, Kurdia A, Ammann L, et al.: The human red blood cell proteome and interactome. Exp Biol Med (Maywood) 2007, 232:1391–1408.CrossRefGoogle Scholar
28. 28.
    Lepedda AJ, Cigliano A, Cherchi GM, et al.: A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. Atherosclerosis 2009, 203:112–118.CrossRefPubMedGoogle Scholar
29. 29.
    •• de Kleijn DP, Moll FL, Hellings WE, et al.: Local atherosclerotic plaques are a source of prognostic biomarkers for adverse cardiovascular events. Arterioscler Thromb Vasc Biol 2010(in press). This is the first study in which proteomics applied to human atherosclerotic plaques identified a biomarker with predictive value for the occurrence of adverse cardiovascular events. Google Scholar
30. 30.
    •• Urbonavicius S, Lindholt JS, Vorum H, et al.: Proteomic identification of differentially expressed proteins in aortic wall of patients with ruptured and nonruptured abdominal aortic aneurysms. J Vasc Surg 2009, 49:455–463. The is the first study in which proteomics were applied to human walls from patients with ruptured AAA.CrossRefPubMedGoogle Scholar
31. 31.
    Martin-Ventura JL, Duran MC, Blanco-Colio LM, et al.: Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis. Circulation 2004, 110:2216–2219.CrossRefPubMedGoogle Scholar
32. 32.
    Blanco-Colio LM, Martín-Ventura JL, Muñóz-García B, et al.: Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis. Arterioscler Thromb Vasc Biol 2007, 27:916–922.CrossRefPubMedGoogle Scholar
33. 33.
    •• Dejouvencel T, Féron D, Rossignol P, et al.: Hemorphin 7 reflects hemoglobin proteolysis in abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 2010, 30:269–275. The is the first study in which proteomics were applied to human thrombus from patients with AAA.CrossRefPubMedGoogle Scholar
34. 34.
    Pernemalm M, Orre LM, Lengqvist J, et al.: Evaluation of three principally different intact protein prefractionation methods for plasma biomarker discovery. J Proteome Res 2008, 7:2712–2722.CrossRefPubMedGoogle Scholar
35. 35.
    Wilson AM, Kimura E, Harada RK, et al.: Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies. Circulation 2007, 116:1396–1403.CrossRefPubMedGoogle Scholar
36. 36.
    Distelmaier K, Adlbrecht C, Jakowitsch J, et al.: Local complement activation triggers neutrophil recruitment to the site of thrombus formation in acute myocardial infarction. Thromb Haemost 2009, 102:564–572.PubMedGoogle Scholar
37. 37.
    Bossi F, Rizzi L, Bulla R, et al.: C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function. Blood 2009, 113:3640–3648.CrossRefPubMedGoogle Scholar
38. 38.
    Pagano MB, Zhou HF, Ennis TL, et al.: Complement-dependent neutrophil recruitment is critical for the development of elastase-induced abdominal aortic aneurysm. Circulation 2009, 119:1805–1813.CrossRefPubMedGoogle Scholar
39. 39.
    Sabatine MS, Liu E, Morrow DA, et al.: Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation 2005, 112:3868–3875.CrossRefPubMedGoogle Scholar
40. 40.
    Brindle JT, Antti H, Holmes E, et al.: Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med 2002, 8:1439–1444.CrossRefPubMedGoogle Scholar
41. 41.
    Brindle JT, Nicholson JK, Schofield PM, et al.: Application of chemometrics to 1H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension. Analyst 2003, 128:32–36.CrossRefPubMedGoogle Scholar
42. 42.
    Kirschenlohr HL, Griffin JL, Clarke SC, et al.: Proton NMR analysis of plasma is a weak predictor of coronary artery disease. Nat Med 2006, 12:705–710.CrossRefPubMedGoogle Scholar
43. 43.
    Vallejo A, Usobiaga A, Martinez-Arkarazo I, et al.: Ultrasonic-assisted derivatization of estrogenic compounds in a cup horn booster and determination by GC-MS. J Sep Sci 2009, 33:104–111.CrossRefGoogle Scholar
44. 44.
    Teul J, Rupérez FJ, Garcia A, et al.: Improving metabolite knowledge in stable atherosclerosis patients by association and correlation of GC-MS and 1H NMR fingerprints. J Proteome Res 2009, 8:5580–5589.CrossRefPubMedGoogle Scholar
45. 45.
    Mayr M, Chung YL, Mayr U, et al.: Proteomic and metabolomic analyses of atherosclerotic vessels from apolipoprotein E-deficient mice reveal alterations in inflammation, oxidative stress, and energy metabolism. Arterioscler Thromb Vasc Biol 2005, 25:2135–2142.CrossRefPubMedGoogle Scholar
46. 46.
    He W, Miao FJ, Lin DC, et al.: Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 2004, 429:188–193.CrossRefPubMedGoogle Scholar
47. 47.
    Lewis GD, Asnani A, Gerszten RE: Application of metabolomics to cardiovascular biomarker and pathway discovery. J Am Coll Cardiol 2008, 52:117–123.CrossRefPubMedGoogle Scholar
48. 48.
    Wheelock CE, Wheelock AM, Kawashima S, et al.: Systems biology approaches and pathway tools for investigating cardiovascular disease. Mol Biosyst 2009, 5:588–602.CrossRefPubMedGoogle Scholar